Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kim, Chong Hwa
NCT04653779: A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg	Not yet recruiting	4	54	RoW	Evogliptin 5mg/Metformin 1000mg, SUGAMET®XR tablet 5/1000mg	Dong-A ST Co., Ltd.	Diabetes Mellitus, Type 2, Renal Disease, Diabetes Mellitus, Metabolic Disease, Endocrine System Diseases	05/21	07/21
AZUR-2, NCT05855200: Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer	Recruiting	3	711	Europe, Canada, Japan, US, RoW	Dostarlimab, CAPEOX, FOLFOX	GlaxoSmithKline	Colonic Neoplasms, Neoplasms, Colon	12/28	12/30
NCT06074562: A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain	Recruiting	2	410	Europe, Japan, US, RoW	LY3556050, Placebo	Eli Lilly and Company	Diabetic Peripheral Neuropathy	07/25	07/25
Young, Amelia
No trials found
Bremer, Nicholas
No trials found